Biotech & Longevity: 22 Jun – 28 Jun
No boards ran in this window, so there is no arc to read.
—
pressure at the week’s end, 0–100
—
move across the week
7
editions published
560
sources read behind them
No written analysis for this week
Everything on this page is measured from the week’s own boards and editions. The written read is added when the engine runs its report pass; a week without one still has its record.
The week’s editions · 7
The week age stopped meaning your birthday — and a body clock predicted cancer
Soil bacteria carry a built-in four-drug antibiotic cocktail — and it's hard to outrun
The company that invented gene editing went bankrupt the week the field had its biggest wins
A US company will sell an unproven anti-ageing gene therapy abroad to skip the FDA
The week three big drug bets failed — and what the winners' headlines hide
The week HIV funding shrank while $745m flowed into the drugs that pay
AbbVie bets nearly $11bn on a biotech whose drugs aren't proven yet — and it wasn't alone this week
The same week, another beat